tiprankstipranks
IMVT Earnings this Week: How Will it Perform?
PremiumPre-EarningsIMVT Earnings this Week: How Will it Perform?
2M ago
JPMorgan SMid cap biotech analyst holds an analyst/industry conference call
Premium
The Fly
JPMorgan SMid cap biotech analyst holds an analyst/industry conference call
2M ago
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
2M ago
Palantir, Dell Technologies named to join S&P 500: Morning Buzz
PremiumThe FlyPalantir, Dell Technologies named to join S&P 500: Morning Buzz
3M ago
Immunovant Advances Groundbreaking Therapy in Graves’ Disease Trials
Premium
Company Announcements
Immunovant Advances Groundbreaking Therapy in Graves’ Disease Trials
3M ago
Roivant Sciences provides update on Graves’ Disease development program
Premium
The Fly
Roivant Sciences provides update on Graves’ Disease development program
3M ago
Immunovant price target lowered to $47 from $48 at Wells Fargo
PremiumThe FlyImmunovant price target lowered to $47 from $48 at Wells Fargo
7M ago
Immunovant reports Q4 EPS (52c), consensus (43c)
Premium
The Fly
Immunovant reports Q4 EPS (52c), consensus (43c)
7M ago
Immunovant management to meet with Piper Sandler
Premium
The Fly
Immunovant management to meet with Piper Sandler
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100